Ding K, Liu H, Ma J, Yang H, Cao L, Wang H, Peng H, Shi W, Zhao X, Wu W, Zhu H, Li J, Fan L. Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial. haematol [Internet]. 2023Aug.1 [cited 2024Nov.28];108(8):2146-54. Available from: https://haematologica.org/article/view/haematol.2022.282266